Exondys 51 Injection
Product Images NDC 60923-284

6 FDA label images from Sarepta Therapeutics, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Exondys 51 (NDC 60923-284). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sarepta Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Exo00 0020 01

Exo00 0020 01
Chemical structure diagram of eteplirsen, showing the nucleotide sequences with breaks labeled A through D. The structure includes detailed chemical representations of the bases adenine (A), cytosine (C), guanine (G), and thymine (T) with molecular annotations. A nucleotide base sequence from the 5' end to the 3' end is also depicted.*
FDA Label Image

Exo00 0020 02

FDA Label Image

Exo00 0020 03

Exo00 0020 03
Exondys 51 (eteplirsen) Injection 100 mg/2 mL (50 mg/mL) carton label for intravenous infusion after dilution. Contains one single-dose vial. The label includes storage instructions to refrigerate at 2°C to 8°C (36°F to 46°F), use a 0.2 micron in-line filter during infusion, and discard unused contents. Manufactured for Sarepta Therapeutics, Inc., Cambridge, MA, USA. Includes detailed ingredient and preservative information.*
FDA Label Image

Exo00 0020 04

Exo00 0020 04
Label for Exondys 51 (eteplirsen) Injection, 100 mg per 2 mL (50 mg/mL) single-dose vial. Manufactured for Sarepta Therapeutics, Inc., Cambridge, MA, USA. The label includes the NDC barcode and NDC number 69082-388-02.*
FDA Label Image

Exo00 0020 05

Exo00 0020 05
Packaging label for Exondys 51 (eteplirsen) Injection, 500 mg/10 mL (50 mg/mL) for intravenous infusion after dilution. The label indicates it is a single-dose vial, contains one vial per carton, and requires use of a 0.2 micron in-line filter during infusion. The labeler is Sarepta Therapeutics, Inc., with storage instructions to refrigerate at 2°C-8°C and protect from light. Ingredients and preservative information are also included.*
FDA Label Image

Exo00 0020 06

Exo00 0020 06
Label for Exondys 51 (eteplirsen) Injection, single dose vial containing 500 mg/10 mL (50 mg/mL) for intravenous infusion. Manufactured for Sarepta Therapeutics, Inc., Cambridge, MA. Storage instructions indicate refrigeration at 2°C-8°C (36°F-46°F).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.